Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

WHEATON® Introduces CryoELITE® for Secure Storage of Biological Tissues

Published: Friday, October 11, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
Specialty containers designed to store and ship tissue samples in cryogenic conditions.

WHEATON® CryoELITE® Tissue Vials were designed for the safe, secure and effective cryopreservation of biological tissue specimens.

Different from cells and biofluids, tissue biospecimens have particular requirements for cryogenic storage (see the WHEATON blog at www.CryoFeed.com for more information).

Offering researchers a uniform vial able to maintain sample integrity while maximizing storage capacity and organization, the WHEATON CryoELITE Tissue Vials feature a wide-mouth opening, 5mL capacity and high integrity closure.

The CryoELITE Tissue Vial offers researchers who work with biological tissue sections ease of use, convenience and security. When users decision depends on sample integrity…Trust that specimen to a WHEATON CryoELITE Tissue Vial.

CryoELITE Tissue Vials are manufactured from low binding, cryogenic-grade virgin polypropylene that meets USP Class VI classification. Lot tested and certified to be free of pyrogens, RNase/DNase and endotoxins, the vials have a sample capacity of 5mL and a storage temperature range of -156°C to 121°C.

The externally threaded cap provides a seal that exceeds DOT and IATA classifications for diagnostic specimens and their transport and is capable of maintaining a secure closure during freeze/thaw procedures. The vials have a flat bottom and a stippled external surface to promote easier handling.

For additional convenience and productivity, WHEATON offers CryoFile Tissue Boxes, specially designed water-repellant boxes for batching and storing 25 vials in numbered partitions.

Available in six colors for quick identification, CryoFile boxes can be double stacked in a standard 2” freezer rack. Together, CryoELITE Tissue Vials and CryoFile Tissue Boxes are an ideal system for biobanks, research and commercial laboratories, or any institution that stores and distributes tissue sections from humans, animals or plants.

“Tissue specimens are considered by most scientific researchers to contain the most valuable information that we can collect in our efforts to discover therapies and possible cures for cancer and many chronic diseases. CryoELITE Tissue Vials were developed in response to the need to maintain these precious specimens in the most pristine form possible,” says Wayne L. Brinster, CEO & President of WHEATON.

“We are very excited to meet the biomedical research community’s demand for secure, reliable, cryogenically proven vessels to store and transport tissues and fluids,” he added.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Wheaton Acquired By One Equity Partners
Acquisition will combine two of the world’s leading brands in laboratory consumables.
Thursday, September 17, 2015
WHEATON® Acquires Chromatography Vial Supply Company, MicroLiter
A specialty brand joins forces with an established industry leader resulting in an expanding product line and support services for the global HPLC market.
Friday, December 21, 2012
Wayne Brinster Joins WHEATON® as President
The company will continue its focus on supporting laboratory research, and packaging for diagnostics and specialty pharmaceutical markets.
Friday, October 26, 2012
WHEATON® Announces Acquisition of CELLine™
WHEATON has acquired the CELLine bioreactor flask line for antibody and protein production from Wilson Wolf Manufacturing Corporation.
Tuesday, July 10, 2012
Scientific News
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!